Ушбу иш иқтибос қилган ишлар

215 та иш

Иш: Angiogenesis and prostate cancer: MicroRNAs comes into view

Сарлавҳасиз
Бошқа3 иқтибос
ABI
Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton
Dos D. Sarbassov, Siraj M. Ali, Do‐Hyung Kim +5
Мақола20042 иқтибос
ABI
Phase I/II study evaluating the safety and clinical efficacy of temsirolimus and bevacizumab in patients with chemotherapy refractory metastatic castration-resistant prostate cancer
Pedro C. Barata, Matthew M. Cooney, Prateek Mendiratta +3
Мақола20182 иқтибос
ABI
Inhibition of transforming growth factor beta/<scp>SMAD</scp> signal by MiR‐155 is involved in arsenic trioxide‐induced anti‐angiogenesis in prostate cancer
Hui Ji, Yuan Li, Fei Jiang +4
Мақола20142 иқтибос
ABI
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao, Bülent Arman Aksoy, Uğur Doğrusöz +10
Мақола20132 иқтибос
ABI
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami, Jianjiong Gao, Uğur Doğrusöz +12
Мақола20122 иқтибос
ABI
The Contribution of Angiogenesis to the Process of Metastasis
Diane R. Bielenberg, Bruce R. Zetter
Шарҳ мақола20152 иқтибос
ABI
Multiple angiogenesis stimulators in a single malignancy: Implications for anti-angiogenic tumour therapy
Helena Pavlaković, W. Havers, Lothar Schweigerer
Мақола20012 иқтибос
ABI
MicroRNA-212 negatively regulates starvation induced autophagy in prostate cancer cells by inhibiting SIRT1 and is a modulator of angiogenesis and cellular senescence
Malathi Ramalinga, Arpita Roy, Anvesha Srivastava +5
Мақола20152 иқтибос
ABI
Intricacies of Bevacizumab-Induced Toxicities and Their Management
Sarah M Gressett, Sachin Shah
Шарҳ мақола20092 иқтибос
ABI
Molecular Pathogenesis and Progression of Prostate Cancer
Randy S. Schrecengost, Karen E. Knudsen
Шарҳ мақола20132 иқтибос
ABI
Molecular mechanisms and clinical applications of angiogenesis
Peter Carmeliet, Rakesh K. Jain
Шарҳ мақола20112 иқтибос
ABI
MicroRNA-Based Therapeutics for Cancer
Vivien Wang, Wei Wu
Шарҳ мақола20092 иқтибос
ABI
PI3K/AKT signaling pathway and cancer: an updated review
Miriam Martini, Maria Chiara De Santis, Laura Braccini +2
Шарҳ мақола20142 иқтибос
ABI
The Role of PTEN in Tumor Angiogenesis
Stéphane Rodriguez, Uyen Huynh‐Do
Мақола20112 иқтибос
ABI
Growing roles for the mTOR pathway
Dos D. Sarbassov, Siraj M. Ali, David M. Sabatini
Шарҳ мақола20052 иқтибос
ABI
MiR‐130b suppresses prostate cancer metastasis through down‐regulation of MMP2
Qin Chen, Xian Zhao, Hailong Zhang +8
Мақола20142 иқтибос
ABI
Forty-Year Journey of Angiogenesis Translational Research
Yihai Cao, Jack L. Arbiser, Robert J. D’Amato +9
Шарҳ мақола20112 иқтибос
ABI
The Risk Factors of Prostate Cancer and Its Prevention: A Literature Review.
Noor Riza Perdana, Chaidir Arif Mochtar, H. Rainy Umbas +1
Мақола20162 иқтибос
ABI
Hostile takeover: how tumours hijack pre‐existing vascular environments to thrive
Frank Winkler
Мақола20172 иқтибос
ABI
Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study
Nico van Zandwijk, Nick Pavlakis, Steven Kao +14
Мақола20172 иқтибос
ABI
Reciprocal regulations between miRNAs and HIF-1α in human cancers
Wanli Yang, Jiaojiao Ma, Wei Zhou +6
Шарҳ мақола20182 иқтибос
ABI
Targeting Angiogenesis in Prostate Cancer
Zsombor Melegh, Sebastian Oltean
Шарҳ мақола20192 иқтибос
ABI
Current Treatment Options for Metastatic Hormone-Sensitive Prostate Cancer
Carlo Cattrini, Elena Castro, R. Lozano Mejorada +4
Шарҳ мақола20192 иқтибос
ABI
Docetaxel Combined with Thymoquinone Induces Apoptosis in Prostate Cancer Cells via Inhibition of the PI3K/AKT Signaling Pathway
Santosh Kumar Singh, Tejumola Apata, Jennifer Gordetsky +1
Мақола20192 иқтибос
ABI